Yu, H <br/><br/>
Market share and costs of biologic therapies for inflammatory bowel disease in the USA.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  02 2018 
 - 364-370 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/apt.14430  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administrative Claims, Healthcare--statistics & numerical data<br/>Adolescent<br/>Adrenal Cortex Hormones--economics<br/>Adult<br/>Biological Products--economics<br/>Biological Therapy--economics<br/>Child<br/>Child, Preschool<br/>Costs and Cost Analysis<br/>Databases, Factual<br/>Female<br/>Health Care Sector--economics<br/>Humans<br/>Immunologic Factors--economics<br/>Infant<br/>Infant, Newborn<br/>Inflammatory Bowel Diseases--drug therapy<br/>Longitudinal Studies<br/>Male<br/>Mesalamine--economics<br/>Retrospective Studies<br/>United States--epidemiology